Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Lands Duke’s Califf As Top Deputy, Potential Next Commissioner

This article was originally published in The Pink Sheet Daily

Executive Summary

Renowned cardiologist and clinical trialist Robert Califf will join FDA in February as deputy commissioner for medical products and tobacco.

You may also be interested in...



The Evolving Door? What Having A ‘Big Data’ Commissioner Might Mean For US FDA

Robert Califf’s nomination to return as FDA commissioner will raise protests about a ‘revolving door’ pathway between industry and agency. But, in this case, it may be more apt to talk about how Califf’s time outside FDA led to evolving views on the role of big data in drug regulation.

Califf Maintains Desire To Stay At FDA, But Would Either Presidential Candidate Keep Him?

FDA Commissioner says every day at FDA is fun, but decision to remain will be made by the next president.

Finally … Rachel Sherman Takes Califf's Old FDA Job

After months of speculation, FDA veteran Rachel Sherman becomes deputy commissioner for medical products and tobacco.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS077813

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel